IgG4-RD
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases (NCT06978738) | Changzhou No.2 People's Hospital | 2025-05-01 |
| Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) (NCT04918147) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-10-13 |
| Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD) (NCT02725476) | Xencor, Inc. | 2016-03-01 |
Track IgG4-RD automatically
Every clearance here is in the API, with alerts when new ones post.